Company intelligence / Profile preview

GenArraytion

Rockville, Maryland, United States

Ownership: Private
Development stage: Other

Overview

GenArraytion's molecular diagnostics platforms, particularly MultiFLEX Bioassays, enable rapid identification of pathogens including emerging infectious viruses and waterborne microorganisms. Their Zika virus test was among the first available for mosquito surveillance, supporting epidemic preparedness. Commercial results focus on research use and public health applications, not clinical outcomes

Therapeutic areas: Infectious Diseases
Modalities: Molecular diagnosticsPCR-based assaysMultiplex assays
Industry: Molecular Diagnostics

Partnerships

Nephros (acquiring company)collaboration with public health bodiesTech Council of Maryland

Beyond the preview

Go deeper on GenArraytion.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GenArraytion.

Explore the full profile